Back    Zoom +    Zoom -
<Research>M Stanley Rates WUXI BIO as Overweight w/ TP HKD35; Positive Profit Alert Beats
Recommend
23
Positive
35
Negative
13
WUXI BIO (02269.HK) has issued a positive profit alert expecting its 1H25 revenue/ net profit/ adjusted net profit to rise by 16%/ 56%/ 11% YoY on a 3.6 ppt YoY expansion in its GPM, surpassing expectations, according to Morgan Stanley's research report.

The broker attributed the GPM expansion to an increase in service projects and improved utilization. The better-than-expected 1H25 results will also provide a buffer for the company's full-year revenue growth guidance of 12-15% and heightened profitability.

Related NewsGuotai Haitong Securities: Mainland Public Funds Continue to Increase Holdings in H Shrs in 2Q, Adding Stocks of Innovative Drugs, New Consumption & Div., Reducing Tech Stocks
Morgan Stanley set its target price for WUXI BIO at HKD35 with an Overweight rating.
AAStocks Financial News